Key facts
- 21 Impact Labs’s last known valuation is $17.7M (Dec 2024).
- It has raised $4.1M; the latest was Early Stage VC ($2.0M) in Dec 2024.
- Notable investors include Boost VC, Collab+Currency, SpaceShip Dao, BeakerDAO.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for 21 Impact Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for 21 Impact Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About 21 Impact Labs
Developer of a decentralized platform designed to fund and support research on brain health and neurodegenerative diseases. The company's platform leverages a community-driven approach to foster collaboration and innovation, access funding and resources for projects, enabling neuroscience researchers to accelerate the development of resolutions and therapeutics to address the growing global challenge of brain health decline.
- Sector
- Financial Services
- HQ
- Boston, MA, United States
- Founded
- 2021
- Employees
- 5
- Website
- 21impactlabs.com/
- Ownership
- Privately Held (backing)
21 Impact Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in 21 Impact Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on 21 Impact Labs in its N-PORT filings yet. We sweep new filings monthly.